Background:

Life Sciences Discovery Fund Authority.

In 2005, the Legislature created the Life Sciences Discovery Fund Authority (Authority) to provide funding opportunities to promote life sciences research. The Authority is governed by an 11-member board, with seven members appointed by the Governor and four members by the Legislature. The Authority is directed to leverage the state's investment in order to promote health, make the life sciences sector more competitive, and strengthen Washington's economy.

In 2013, the Legislature directed the Authority to expend a portion of the Life Sciences Discover Fund (Fund)'s appropriation solely to promote the development and delivery of global health technologies and products. In 2015, the Authority was directed to advise the Liquor and Cannabis Board in granting marijuana research licenses.

Life Sciences Discovery Fund.

The Authority's Board, or the Board's designee, may authorize expenditures from the Fund. The Fund consists in large part of revenues from multi-state tobacco settlement payments, called "strategic contribution payments." Strategic contribution payments began in 2008 and will terminate in 2017. In 2015, a portion of the revenues from strategic contribution payments was allocated to the State General Fund instead of to the Fund.

Cancer Research Endowment Authority.

In 2015, the Legislature created the Cancer Research Endowment Authority (CREA). The CREA is to be governed by a 13-member board of trustees appointed by the Governor. Members must be representatives of research universities, cancer research institutions, patient advocacy organizations, businesses engaged in commercialization of life sciences or cancer research, health care delivery systems, the Legislature, fund donors, and the public.

Cancer Research Endowment Program.

The CREA must oversee and develop a plan for allocation of funds in a Cancer Research Endowment Program. The purpose of the program is to make grants to public and private entities, including commercial entities, to fund or reimburse the entities for cancer research to be conducted in the state. The CREA must establish one or more scientific review and advisory committees for the purposes of evaluating grant proposals for cancer research and making recommendations for funding.

Role of a Program Administrator.

The CREA must contract with a program administrator to provide services including solicitation of grants, gifts and donations; grant distribution; and fund management. The program administrator must be a private nonprofit corporation with expertise in conducting or managing research granting activities, funds, or organizations.

CARE Fund.

The program administrator must also establish the Cancer Research Endowment Fund outside the state Treasury for the deposit of grants and contributions received from public and private sources. Assets in the CARE Fund are not considered state revenue. Funds must be used to fund grants for the Cancer Research Endowment Program. The program administrator must take such action as necessary to enable the CARE Fund to accept charitable contributions.

Cancer Research Endowment Fund Match Transfer Account.

The Cancer Research Endowment Fund Match Transfer Account (Account) is created in the custody of the State Treasurer. Funds in the Account are used to provide matching funds for the CARE Fund and administrative costs. The Director of Commerce may make expenditures from the account for deposit into the CARE Fund upon proof of nonstate or private contributions to the CARE Fund. Expenditures may not exceed the total amount of nonstate or private contributions.

Tobacco Tax Enforcement.

Beginning July 1, 2016, the Cancer Research Endowment Fund Match Transfer Account may receive up to $10 million each fiscal year from tax collections and penalties generated from enforcement of state taxes on cigarettes and other tobacco products. The program administrator may provide technical assistance, information, and training to private employers and other potential donors to establish programs that facilitate charitable contributions to the CARE Fund, including tobacco use surcharge programs.

Summary of Bill:

Center of Excellence for Life Sciences and Cancer Research.

A Center of Excellence for Life Sciences and Cancer Research (Center) is created to promote sustained investment in life sciences and cancer research. The Center's powers are exercised by the Life Sciences Discovery Fund Authority (Authority). The Center is also encouraged to submit a report to the Legislature by December 1, 2016, with recommendations for how the state can recruit top graduate student talent in the fields of life sciences and cancer research.

Cancer Research Program.

A Cancer Research Program is created within the Center. The purpose of the Cancer Research Program is to make grants to public and private entities, including commercial entities, to fund or reimburse the entities pursuant to agreement for the promotion of cancer research to be conducted in the state. "Cancer research" means advanced and applied research and development relating to the causes, prevention, and diagnosis of cancer and care of cancer patients, including the development of tests, genetic analysis, medications, processes, services, and technologies to optimize cancer therapies and their manufacture and commercialization, and includes the costs of recruiting scientists and establishing and equipping research facilities.

The Authority must oversee and guide the program, including the solicitation, selection, and award of grants. The Authority must develop and annually update a plan for the allocation of projected amounts in the Cancer Research Fund and the CARE Fund. Grant agreements from either fund must set forth the terms and conditions of the grant, including deliverables, circumstances where repayment or revenue-sharing would be necessary, and other terms.

Independent Expert Scientific Review and Advisory Committee.

The Authority must establish one or more independent expert scientific review and advisory committees (Committee) for the purposes of evaluating grant proposals for cancer research and making recommendations for funding. The Committee must consist of individuals with nationally recognized expertise in the scientific, clinical, ethical, commercial, and regulatory aspects of cancer research, prevention, and care. The Authority's Board must appoint the Committee's members. The Authority may not award a cancer research program grant for a proposal that was not recommended by an independent expert scientific review and advisory committee.

Cancer Research Fund.

The Cancer Research Endowment Fund Match Transfer Account, a nonappropriated account in the custody of the State Treasurer, is modified and renamed the Cancer Research Fund. The Authority's Board or its designee may authorize expenditures from the Cancer Research Fund to provide matching funds for cancer research grants and contributions, and administrative costs. The matched grants and contributions may be pledged by public and private sources, and may be pledged to public and private entities, including commercial entities. Expenditures may only be made as matching funds after the Authority has received proof from the prospective grantee that the grantee has received a commitment of public or private contributions equal to or exceeding the expenditure.

CARE Fund.

The existing CARE Fund is repealed and a new CARE Fund is established, also as a separate private account outside of the treasury. Grants and contributions from nonstate public and private sources may be deposited in the CARE Fund. Assets in the CARE Fund are not considered state revenue. Funds must be used to fund grants for the Cancer Research Program. The Authority may create additional legal entities and take such action as may be necessary or advisable to enable the CARE Fund to accept charitable contributions.

Tobacco Tax Enforcement.

Beginning July 1, 2016, the Cancer Research Fund may receive up to $10 million each fiscal year from tax collections and penalties generated from enforcement of state taxes on cigarettes and other tobacco products.